Regenerative Medical Technology (RMTG) Treasury Shares (2020 - 2025)
Historic Treasury Shares for Regenerative Medical Technology (RMTG) over the last 5 years, with Q3 2025 value amounting to $132.5 million.
- Regenerative Medical Technology's Treasury Shares rose 8932.35% to $132.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $132.5 million, marking a year-over-year increase of 8932.35%. This contributed to the annual value of $70.0 million for FY2024, which is 2000.0% down from last year.
- According to the latest figures from Q3 2025, Regenerative Medical Technology's Treasury Shares is $132.5 million, which was up 8932.35% from $82.5 million recorded in Q2 2025.
- In the past 5 years, Regenerative Medical Technology's Treasury Shares ranged from a high of $132.5 million in Q3 2025 and a low of $70.0 million during Q3 2024
- Its 4-year average for Treasury Shares is $88.0 million, with a median of $82.5 million in 2025.
- As far as peak fluctuations go, Regenerative Medical Technology's Treasury Shares crashed by 2000.0% in 2024, and later soared by 8932.35% in 2025.
- Quarter analysis of 4 years shows Regenerative Medical Technology's Treasury Shares stood at $103.5 million in 2022, then dropped by 15.46% to $87.5 million in 2023, then dropped by 20.0% to $70.0 million in 2024, then surged by 89.32% to $132.5 million in 2025.
- Its Treasury Shares was $132.5 million in Q3 2025, compared to $82.5 million in Q2 2025 and $70.0 million in Q1 2025.